RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
(Abstracted from Lancet Oncol 2020;21:175–184) Cervical cancer has a long and treatable precancerous phase, is easily screened for, and is common enough to justify population-based screening even in low- and middle-income countries (LMICs). The standard treatment in high-income countries is large loop excision of the transformation zone (LLETZ).
Pilot phase of a randomized controlled trial
Pinder, L. F., Parham, G. P., Basu, P., Muwonge, R., Lucas, E., Nyambe, N., Sauvaget, C., Mwanahamuntu, M. H., Sankaranarayanan, R., & Prendiville, W. (2020). (Abstracted from Lancet Oncol 2020;21:175–184) Cervical cancer has a long and treatable precancerous phase, is easily screened for, and is common enough to justify population-based screening even in low- and middle-income countries (LMICs). The standard treatment in high-income countries is large loop excision of the transformation zone (LLETZ). Pilot phase of a randomized controlled trial. Obstetrical & Gynecological Survey, 75(4), 234-235. https://doi.org/10.1097/ogx.0000000000000781